In spring 2018, the Centers for Disease Control released a call to action to address health disparities among Americans with diabetes, heart disease and stroke through CDC-1815. In response, the South Dakota State University College of Pharmacy and Allied Health Professions and the South Dakota Department of Health collaborated to create a five-year plan to identify barriers and develop viable solutions to improve the care of South Dakotans with diabetes and cardiovascular disease (CVD). A key focus area is the expansion of the role of the pharmacist as a key member of the healthcare team as it relates to medication therapy management (MTM) and pharmacy’s role in patient care. By working with patient, practitioner, and payer stakeholder groups, the partnership will create a state-wide sustainable and financially viable community-based practice model that helps with prevention and management of diabetes and cardiovascular disease. This work is part of the CDC funded 1815 cooperative agreement focusing on promoting the adoption of MTM between pharmacists and physicians for the purpose of managing high blood pressure, high blood cholesterol and lifestyle management and increasing engagement of pharmacists in the provision of medication management or DSMES (diabetes self-management education and support) for people with diabetes.
Principal Investigator: Sharrel Pinto, B.S. Pharm, D.M.M., M.S., Ph.D.
Funding Acknowledgement: This project was completed in collaboration with the South Dakota Department of Health, supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services under grant # 1 NU58DP006526-01-11. The contents are those of the author(s) and do not necessarily represent the views of CDC or the U.S. Government.